Compare ELTK & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTK | COCH |
|---|---|---|
| Founded | 1970 | 1995 |
| Country | Israel | United States |
| Employees | N/A | 47 |
| Industry | Electrical Products | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 47.1M |
| IPO Year | 1998 | N/A |
| Metric | ELTK | COCH |
|---|---|---|
| Price | $8.31 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 3.7K | ★ 176.1K |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.18 | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $0.36 |
| 52 Week High | $12.19 | $1.91 |
| Indicator | ELTK | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 50.42 |
| Support Level | $7.79 | $0.64 |
| Resistance Level | $9.34 | $0.73 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 54.89 | 60.92 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.